Cargando…

Unlocking the Non-IgE-Mediated Pseudo-Allergic Reaction Puzzle with Mas-Related G-Protein Coupled Receptor Member X2 (MRGPRX2)

Mas-related G-protein coupled receptor member X2 (MRGPRX2) is a class A GPCR expressed on mast cells. Mast cells are granulated tissue-resident cells known for host cell response, allergic response, and vascular homeostasis. Immunoglobulin E receptor (FcεRI)-mediated mast cell activation is a well-s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Mukesh, Duraisamy, Karthi, Chow, Billy-Kwok-Chong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146469/ https://www.ncbi.nlm.nih.gov/pubmed/33925682 http://dx.doi.org/10.3390/cells10051033

Ejemplares similares

Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2)
por: Kumar, Mukesh, et al.
Publicado: (2020)

Determination of key residues in MRGPRX2 to enhance pseudo-allergic reactions induced by fluoroquinolones
por: Hamamura-Yasuno, Eri, et al.
Publicado: (2022)

Identification of the dog orthologue of human MAS-related G protein coupled receptor X2 (MRGPRX2) essential for drug-induced pseudo-allergic reactions
por: Hamamura-Yasuno, Eri, et al.
Publicado: (2020)

Mas-Related G Protein-Coupled Receptor-X2 (MRGPRX2) in Drug Hypersensitivity Reactions
por: Porebski, Grzegorz, et al.
Publicado: (2018)

Mas-related G protein-coupled receptor MRGPRX2 in human basophils: Expression and functional studies
por: Toscano, Alessandro, et al.
Publicado: (2023)

GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells via MRGPRX2 and MRGPRB2
por: Thapaliya, Monica, et al.
Publicado: (2022)

MRGPRX2 and Adverse Drug Reactions
por: McNeil, Benjamin D.
Publicado: (2021)

Liquiritin inhibits MRGPRX2-mediated pseudo-allergy through the PI3K/AKT and PLCγ signaling pathways
por: Wang, Lu, et al.
Publicado: (2023)

MRGPRX2, atopic dermatitis, and red man syndrome
por: Azimi, Ehsan, et al.
Publicado: (2017)

Therapeutic Potential of MRGPRX2 Inhibitors on Mast Cells
por: Ogasawara, Hiroyuki, et al.
Publicado: (2021)

Endocannabinoid System Unlocks the Puzzle of Autism Treatment via Microglia
por: Su, Tangfeng, et al.
Publicado: (2021)

Nasal IgE in subjects with allergic and non-allergic rhinitis
por: Eckrich, Jonas, et al.
Publicado: (2020)

Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE(+) B cells
por: Hu, Jiayun, et al.
Publicado: (2018)

The Multifaceted Mas-Related G Protein-Coupled Receptor Member X2 in Allergic Diseases and Beyond
por: Quan, Paola Leonor, et al.
Publicado: (2021)

Local IgE in patients with allergic rhinitis
por: Rodrigues, Adriana Teixeira, et al.
Publicado: (2015)

In silico design of novel probes for the atypical opioid receptor MRGPRX2
por: Lansu, Katherine, et al.
Publicado: (2017)

Biological screening of a unique drug library targeting MRGPRX2
por: Yang, Fan, et al.
Publicado: (2022)

Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function
por: Varricchi, Gilda, et al.
Publicado: (2019)

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones
por: Elst, Jessy, et al.
Publicado: (2021)

MRGPRX2 signaling involves the Lysyl-tRNA synthetase and MITF pathway
por: Guo, Yanru, et al.
Publicado: (2023)

New strategies with anti-IgE in allergic diseases
por: Holgate, Stephen T
Publicado: (2014)

IgE Sialylation is a Determinant of Allergic Pathogenicity
por: Shade, Kai-Ting C., et al.
Publicado: (2020)

Tracing IgE-Producing Cells in Allergic Patients
por: Eckl-Dorna, Julia, et al.
Publicado: (2019)

Omalizumab and IgE in the Control of Severe Allergic Asthma
por: Gon, Yasuhiro, et al.
Publicado: (2022)

Puzzling Out Synaptic Vesicle 2 Family Members Functions
por: Bartholome, Odile, et al.
Publicado: (2017)

Cell-bound IgE and plasma IgE as a combined clinical diagnostic indicator for allergic patients
por: Qiu, Chuanghua, et al.
Publicado: (2020)

MRGPRX2-mediated mast cell response to drugs used in perioperative procedures and anaesthesia
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2018)

Elevated MRGPRX2 Levels Related to Disease Severity in Patients With Chronic Spontaneous Urticaria
por: Cao, Thi Bich Tra, et al.
Publicado: (2021)

Inhibition of Mast Cell Degranulation in Atopic Dermatitis by Celastrol through Suppressing MRGPRX2
por: Yao, Ciyu, et al.
Publicado: (2023)

Elevated, FcεRI‐dependent MRGPRX2 expression on basophils in chronic urticaria
por: Bartko, Ewa A., et al.
Publicado: (2022)

PACAP activates MRGPRX2 on meningeal mast cells to drive migraine-like pain
por: Sbei, Sami, et al.
Publicado: (2023)

Relationship among total tear IgE, specific serum IgE, and total serum IgE levels in patients with pollen-induced allergic conjunctivitis
por: Yamana, Yasuo, et al.
Publicado: (2021)

Omalizumab in the management of patients with allergic (IgE-mediated) asthma
por: Sandström, Thomas
Publicado: (2009)

An IgE-Mediated Allergic Reaction Caused by Mulberry Fruit
por: Choi, Jong Hyun, et al.
Publicado: (2015)

Extracorporeal IgE Immunoadsorption in Allergic Asthma: Safety and Efficacy
por: Lupinek, Christian, et al.
Publicado: (2017)

Anti-IgE: A treatment option in allergic rhinitis?
por: Pfaar, Oliver, et al.
Publicado: (2021)

dIvergEnt: How IgE Axis Contributes to the Continuum of Allergic Asthma and Anti-IgE Therapies
por: Palomares, Óscar, et al.
Publicado: (2017)

Human Milk and Allergic Diseases: An Unsolved Puzzle
por: Munblit, Daniel, et al.
Publicado: (2017)

Activation of ryanodine-sensitive calcium store drives pseudo-allergic dermatitis via Mas-related G protein-coupled receptor X2 in mast cells
por: Wang, Zhao, et al.
Publicado: (2023)

Osthole, a Natural Plant Derivative Inhibits MRGPRX2 Induced Mast Cell Responses
por: Callahan, Brianna N., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_icbq655f7neiupc0dckisc73l8